- Home
- LNTH vs BFAM Comparison
LNTH vs BFAM Comparison
Compare LNTH & BFAM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LNTH
- BFAM
- Stock Information
- Founded
- LNTH 1956
- BFAM 1986
- Country
- LNTH United States
- BFAM United States
- Employees
- LNTH N/A
- BFAM N/A
- Industry
- LNTH Biotechnology: In Vitro & In Vivo Diagnostic Substances
- BFAM Other Consumer Services
- Sector
- LNTH Health Care
- BFAM Consumer Discretionary
- Exchange
- LNTH Nasdaq
- BFAM Nasdaq
- Market Cap
- LNTH 7.5B
- BFAM 6.9B
- IPO Year
- LNTH 2015
- BFAM 1997
- Fundamental
- Price
- LNTH $73.86
- BFAM $129.16
- Analyst Decision
- LNTH Strong Buy
- BFAM Buy
- Analyst Count
- LNTH 5
- BFAM 8
- Target Price
- LNTH $133.80
- BFAM $139.13
- AVG Volume (30 Days)
- LNTH 1.5M
- BFAM 473.1K
- Earning Date
- LNTH 05-07-2025
- BFAM 05-05-2025
- Dividend Yield
- LNTH N/A
- BFAM N/A
- EPS Growth
- LNTH N/A
- BFAM 93.82
- EPS
- LNTH 3.53
- BFAM 2.77
- Revenue
- LNTH $1,536,699,000.00
- BFAM $2,728,831,000.00
- Revenue This Year
- LNTH $4.63
- BFAM $9.64
- Revenue Next Year
- LNTH $9.35
- BFAM $7.16
- P/E Ratio
- LNTH $20.92
- BFAM $46.07
- Revenue Growth
- LNTH 12.53
- BFAM 9.71
- 52 Week Low
- LNTH $73.11
- BFAM $100.59
- 52 Week High
- LNTH $126.89
- BFAM $141.90
- Technical
- Relative Strength Index (RSI)
- LNTH 26.09
- BFAM 57.04
- Support Level
- LNTH $73.11
- BFAM $121.33
- Resistance Level
- LNTH $81.50
- BFAM $129.56
- Average True Range (ATR)
- LNTH 3.44
- BFAM 3.33
- MACD
- LNTH -1.23
- BFAM 0.33
- Stochastic Oscillator
- LNTH 2.10
- BFAM 66.03
About LNTH Lantheus Holdings Inc.
Lantheus Holdings Inc caters to the United States healthcare sector with the development of diagnostic products. Its products are in three categories: Precision Diagnostics, Radiopharmaceutical Oncology, and Strategic Partnerships and Other Revenue. Precision Diagnostic products assist healthcare professionals Find and Follow diseases, with a focus in cardiology. Radiopharmaceutical Oncology diagnostics and therapeutics help HCPs Find, Fight and Follow cancer. Strategic Partnerships focus on enabling precision medicine through the use of biomarkers, digital solutions and pharma services platforms, and also includes license of RELISTOR to Bausch Health Companies, Inc.
About BFAM Bright Horizons Family Solutions Inc.
Bright Horizons Family Solutions Inc provides education and care solutions designed to help employers support their employees in managing their work/life balance. The company has three business segments: full-service center-based child care, backup care, and educational advisory services. The vast majority of the company's revenue is generated by full-service center-based child care, which includes traditional center-based child care and early education services. Other services provided by the company include in-home child and elder care, tuition assistance, and education consulting. The company earns more than half of its revenue in North America.